FDA Greenlights New Home COVID-19 Testing Kit. What's The Significance?

Nov 20, 2020
Originally published on November 20, 2020 2:39 pm

With cases of COVID-19 surging around the country, testing facilities are having trouble keeping up with demand, and the American Clinical Laboratory Association says it’s running out of critical testing supplies.

Under that backdrop, the Food and Drug Administration greenlighted a new home test — the “COVID-19 All-In-One Test Kit” by Lucira Health.

The prescription-only kit will cost less than $50 and provide users results in about half an hour. How significant of a public health impact will this have?

Host Peter O’Dowd talks to the Cleveland Clinic’s Dr. Gary Procop, medical director of clinical virology whose lab participated in the clinical trial.

This article was originally published on WBUR.org.

Copyright 2020 NPR. To see more, visit https://www.npr.org.